(E)-3-(2-Methylpyridin-4-yl)acrylic acid, 98%, 500mg

1-Amino-3-bromopyridin-1-ium 2,4,6-trimethylbenzenesulfonate, 95.0%, 500mg

1,2-Bis((2S,5S)-2,5-diethylphospholan-1-yl)benzene, 97%, 1g

tert-Butyl 5-chloro-3-oxo-3H-spiro[isobenzofuran-1,4'-piperidine]-1'-carboxylate, 95.0%, 1g

(1s,4s)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclohexanecarboxylic acid, 99.0%, 5g

2-(4-Chloro-3-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98.0%, 250mg

9-(2-Bromoethyl)carbazole>98.0%(GC)5g

5-Bromo-2-chloro-4-methoxypyridine, 95.0%, 5g

Methyl (S)-4-(pyrrolidin-2-yl)benzoate hydrochloride, 95% HPLC, 100mg

7-BROMOCHROMAN-4-OL, 95.0%, 5g

(2E)-3-(3-bromophenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

5-Bromo-4,4-dimethyl-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 250mg

N-(2,2,6,6-tetramethylpiperidin-4-yl)acrylamide, 97%, 5g